AMBALAL SARABHAI ENTERPRISES
Back to Income Statement
|
AMBALAL SARABHAI ENTERPRISES Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹196 Cr | ₹174 Cr | ₹170 Cr | ₹197 Cr | ₹164 Cr |
What is the latest Revenue of AMBALAL SARABHAI ENTERPRISES ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹196 Cr |
| Mar2024 | ₹174 Cr |
| Mar2023 | ₹170 Cr |
| Mar2022 | ₹197 Cr |
| Mar2021 | ₹164 Cr |
How is Revenue of AMBALAL SARABHAI ENTERPRISES Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹196 Cr | 13.03 | |
| Mar2024 | ₹174 Cr | 1.93 | |
| Mar2023 | ₹170 Cr | -13.45 | |
| Mar2022 | ₹197 Cr | 20.23 | |
| Mar2021 | ₹164 Cr | - | |
Compare Revenue of peers of AMBALAL SARABHAI ENTERPRISES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AMBALAL SARABHAI ENTERPRISES | ₹262.3 Cr | -2.3% | 10.9% | -8.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,145.0 Cr | -0.7% | -3.6% | 6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,989.0 Cr | 1.1% | -1.2% | -0.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,322.0 Cr | 1.6% | 1.4% | 36.7% | Stock Analytics | |
| CIPLA | ₹112,149.0 Cr | 0.7% | 2.6% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,483.0 Cr | -0.9% | -2.5% | 1.2% | Stock Analytics | |
AMBALAL SARABHAI ENTERPRISES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AMBALAL SARABHAI ENTERPRISES | -2.3% |
10.9% |
-8.1% |
| SENSEX | -1% |
-5.7% |
-9.7% |
You may also like the below Video Courses